AI-Enabled Stethoscope Boosts Diagnosis of Pregnancy-Related Cardiomyopathy
TUESDAY, Sept. 10, 2024 (HealthDay News) — In pregnant and postpartum women, artificial...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 678 results for 'cardiomyopathy'
HELIOS-B: Vutrisiran Candidate for Standard-of-Care in ATTR Cardiomyopathy
Patients with transthyretin amyloidosis with cardiomyopathy had a reduced all-cause mortality and recurrent cardiovascular events with intake of vutrisiran in the HELIOS-B study.
Read MoreGenetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project.
Cardiomyopathies are a group of inherited heart muscle disorders. Expressivity is variable and while sometimes mild, complications can result in sudden cardiac death (SCD) at any age, heart failure and stroke. In around a third...
Read More
Predictors of Dilated Cardiomyopathy in Genetic Penetrance
The following is a summary of “Genetic Penetrance in Dilated Cardiomyopathy,” published in the...
Read More
Aficamten improves oxygen uptake in patients with obstructive hypertrophic cardiomyopathy
1. In this randomized controlled trial, aficamten significantly improved peak oxygen uptake in...
Read More
Enhancing Cardiomyopathy Outcomes through a Genotype-First Approach
The following is a summary of “Genotype-First Approach to Cardiomyopathy Outcomes,” published in...
Read More
#VisualAbstract: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine,...
Read More
Aficamten Significantly Improves Peak Oxygen Uptake in Obstructive Hypertrophic Cardiomyopathy
Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly...
Read MoreImpact of tafamidis on myocardial function and CMR tissue characteristics in transthyretin amyloid cardiomyopathy.
Tafamidis improves clinical outcomes in transthyretin amyloid cardiomyopathy (ATTR-CM), yet how tafamidis affects cardiac structure and function remains poorly described. This study prospectively analysed the effect of tafamidis...
Read MoreAdvertisement
Guidelines Developed for Management of Hypertrophic Cardiomyopathy
THURSDAY, May 9, 2024 (HealthDay News) — In a new clinical guideline issued by the American...
Read More
ACC Finds Significant Cardiomyopathy Risk for Young Adults Prescribed ADHD Meds
Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD)...
Read More
Artificial Intelligence‐Augmented ECG Algorithms Predict MACE in Takotsubo Cardiomyopathy
AI-ECG may have clinical implications and provide additional insight into general risk stratification among patients with Takotsubo cardiomyopathy.
Read MorePaced QRS morphology mimicking complete left bundle branch block induced by right ventricular pacing is associated with pacing-induced cardiomyopathy.
Right ventricular (RV) pacing sometimes causes left ventricular (LV) systolic dysfunction, also known as pacing-induced cardiomyopathy (PICM). However, the association between specifically paced QRS morphology and PICM...
Read MoreHistological and functional assessment of a Takotsubo cardiomyopathy model established by immobilization stress.
Takotsubo cardiomyopathy (TTC), also known as stress-induced cardiomyopathy, resembles acute heart failure syndrome but lacks disease-specific diagnosis and treatment strategies. TTC accounts for approximately 5-6% of all...
Read More
#VisualAbstract: Acoramidis is an efficacious treatment for transthyretin amyloid cardiomyopathy compared to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
Acoramidis slows disease progression in transthyretin amyloid cardiomyopathy
1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy...
Read MoreExploration and validation of signature genes and immune associations in septic cardiomyopathy.
An early and accurate diagnosis of septic cardiomyopathy is vital for improving the overall prognosis of sepsis. In our research, we aimed to identify signature genes and their immune connections in septic cardiomyopathy. By...
Read More
Acoramidis Beneficial in Transthyretin Amyloid Cardiomyopathy
THURSDAY, Jan. 11, 2024 (HealthDay News) — Acoramidis yields a significantly better...
Read MoreProlonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study.
Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias and other arrhythmias. Screening for arrhythmias is mandatory to assess the individual SCD risk,...
Read More
Tafamidis attenuates the decline of cardiac function in patients with transthyretin amyloid cardiomyopathy
1. Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) managed with tafamidis showed...
Read More